case_images: PMC5602651_01
case_images: PMC5602651_02
case_images: Height growth chart for Case 1.
case_images: CRIE2017-7287351.001.jpg
case_images: PMC5602651_02_CRIE2017-7287351.001.jpg
case_images: fig1
case_images: The patient was started on growth hormone (GH) at 39 mug/kg/day, with resultant increased growth velocity (Figure 1).
case_images: Height growth chart for Case 2.
case_images: CRIE2017-7287351.002.jpg
case_images: PMC5602651_02_CRIE2017-7287351.002.jpg
case_images: fig2
case_images: A representative growth chart is provided in Figure 2.
case_images: PMC5602651_03
case_images: Height growth chart for Case 3.
case_images: CRIE2017-7287351.003.jpg
case_images: PMC5602651_03_CRIE2017-7287351.003.jpg
case_images: fig3
case_images: Case 3 was the eldest child, and her GH treatment was discontinued at age 13 years and 4 months as she neared completion of linear growth after menarche (Figure 3).